594 related articles for article (PubMed ID: 1363009)
1. Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus.
Lehmann R; von Beust B; Niederer E; Condrau MA; Fierz W; Aubert A; Ackley CD; Cooper MD; Tompkins MB; Lutz H
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):199-214. PubMed ID: 1363009
[TBL] [Abstract][Full Text] [Related]
2. Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.
Hofmann-Lehmann R; Holznagel E; Aubert A; Ossent P; Reinacher M; Lutz H
Vet Immunol Immunopathol; 1995 May; 46(1-2):127-37. PubMed ID: 7618252
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine.
Lehmann R; Franchini M; Aubert A; Wolfensberger C; Cronier J; Lutz H
J Am Vet Med Assoc; 1991 Nov; 199(10):1446-52. PubMed ID: 1666101
[TBL] [Abstract][Full Text] [Related]
4. Effects of incidental infections and immune activation on disease progression in experimentally feline immunodeficiency virus-infected cats.
Reubel GH; Dean GA; George JW; Barlough JE; Pedersen NC
J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1003-15. PubMed ID: 7916048
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha levels in cats experimentally infected with feline immunodeficiency virus: effects of immunization and feline leukemia virus infection.
Lehmann R; Joller H; Haagmans BL; Lutz H
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):61-9. PubMed ID: 1337403
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of CD4%:CD8 low% T-lymphocyte ratio to differentiate feline immunodeficiency virus (FIV)-infected from FIV-vaccinated cats.
Litster A; Lin JM; Nichols J; Weng HY
Vet Microbiol; 2014 Jun; 170(3-4):197-205. PubMed ID: 24559863
[TBL] [Abstract][Full Text] [Related]
7. Interaction of acute feline herpesvirus-1 and chronic feline immunodeficiency virus infections in experimentally infected specific pathogen free cats.
Reubel GH; George JW; Barlough JE; Higgins J; Grant CK; Pedersen NC
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):95-119. PubMed ID: 1363011
[TBL] [Abstract][Full Text] [Related]
8. Comparison of T-cell subpopulations in cats naturally infected with feline leukaemia virus or feline immunodeficiency virus.
Hoffmann-Fezer G; Mortelbauer W; Hartmann K; Mysliwietz J; Thefeld S; Beer B; Thum I; Kraft W
Res Vet Sci; 1996 Nov; 61(3):222-6. PubMed ID: 8938851
[TBL] [Abstract][Full Text] [Related]
9. Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets.
Hofmann-Lehmann R; Holznagel E; Ossent P; Lutz H
Clin Diagn Lab Immunol; 1997 Jan; 4(1):33-42. PubMed ID: 9008278
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte population changes in cats naturally infected with feline immunodeficiency virus.
Novotney C; English RV; Housman J; Davidson MG; Nasisse MP; Jeng CR; Davis WC; Tompkins MB
AIDS; 1990 Dec; 4(12):1213-8. PubMed ID: 1982410
[TBL] [Abstract][Full Text] [Related]
11. Selective thymocyte depletion and immunoglobulin coating in the thymus of cats infected with feline immunodeficiency virus.
Orandle MS; Papadi GP; Bubenik LJ; Dailey CI; Johnson CM
AIDS Res Hum Retroviruses; 1997 May; 13(7):611-20. PubMed ID: 9135879
[TBL] [Abstract][Full Text] [Related]
12. Impaired T-cell priming and proliferation in cats infected with feline immunodeficiency virus.
Bishop SA; Williams NA; Gruffydd-Jones TJ; Harbour DA; Stokes CR
AIDS; 1992 Mar; 6(3):287-93. PubMed ID: 1348945
[TBL] [Abstract][Full Text] [Related]
13. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
[TBL] [Abstract][Full Text] [Related]
14. Persistent upregulation of MHC class II antigen expression on T-lymphocytes from cats experimentally infected with feline immunodeficiency virus.
Rideout BA; Moore PF; Pedersen NC
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):71-81. PubMed ID: 1363010
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses.
Sahay B; Aranyos AM; Mishra M; McAvoy AC; Martin MM; Pu R; Shiomitsu S; Shiomitsu K; Dark MJ; Sanou MP; Roff SR; Rathore MH; Yamamoto JK
Viruses; 2019 Feb; 11(2):. PubMed ID: 30717485
[TBL] [Abstract][Full Text] [Related]
16. FIV vaccine studies. II. Clinical findings, hematological changes and kinetics of blood lymphocyte subsets.
Hofmann-Lehmann R; Holznagel E; Aubert A; Bauer-Pham K; Lutz H
Vet Immunol Immunopathol; 1995 May; 46(1-2):115-25. PubMed ID: 7618251
[TBL] [Abstract][Full Text] [Related]
17. 16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppression.
Pedersen NC; North TW; Rigg R; Reading C; Higgins J; Leutenegger C; Henderson GL
Vet Immunol Immunopathol; 2003 Aug; 94(3-4):133-48. PubMed ID: 12909410
[TBL] [Abstract][Full Text] [Related]
18. Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins.
Leutenegger CM; Hofmann-Lehmann R; Holznagel E; Cuisinier AM; Wolfensberger C; Duquesne V; Cronier J; Allenspach K; Aubert A; Ossent P; Lutz H
AIDS Res Hum Retroviruses; 1998 Feb; 14(3):275-83. PubMed ID: 9491919
[TBL] [Abstract][Full Text] [Related]
19. Diagnosing feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) infection: an update for clinicians.
Westman ME; Malik R; Norris JM
Aust Vet J; 2019 Mar; 97(3):47-55. PubMed ID: 30809813
[TBL] [Abstract][Full Text] [Related]
20. Feline immunodeficiency virus (FIV) infection leads to increased incidence of feline odontoclastic resorptive lesions (FORL).
Hofmann-Lehmann R; Berger M; Sigrist B; Schawalder P; Lutz H
Vet Immunol Immunopathol; 1998 Oct; 65(2-4):299-308. PubMed ID: 9839881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]